BNP PARIBAS ARBITRAGE/CALL/SANOFI/100/0.2/20.12.24 Share Price

Warrant

3C2NB

NLBNPFR1YGI6

Market Closed - Euronext Paris 17:30:01 27/05/2024 BST
0.58 EUR +3.57% Intraday chart for BNP PARIBAS ARBITRAGE/CALL/SANOFI/100/0.2/20.12.24
Current month-12.12%
1 month-1.69%
Date Price Change
27/05/24 0.58 +3.57%
24/05/24 0.56 -9.68%
23/05/24 0.62 -6.06%
22/05/24 0.66 +8.20%
21/05/24 0.61 +3.39%

Real-time Euronext Paris

Last update May 27, 2024 at 05:30 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer BNP Paribas BNP Paribas
3C2NB
ISINNLBNPFR1YGI6
Date issued 19/02/2024
Strike 100
Maturity 20/12/2024 (207 Days)
Parity 5 : 1
Emission price 0.36
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.89
Lowest since issue 0.3
Spread 0.02
Spread %3.57%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
89.86 EUR
Average target price
108.2 EUR
Spread / Average Target
+20.40%
Consensus
  1. Stock Market
  2. Warrants
  3. 3C2NB Warrant